When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
<iframe src="https://statesidedaily.com/embed/cluster/ffddec10b8d84a752ba2d2c439cb87739683b243" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="When AI designs a drug, who gets the credit?"></iframe>